SPY312.18+4.10 1.33%
DIA263.17+5.32 2.06%
IXIC9,682.91+74.54 0.78%

HC Wainwright & Co. Reiterates Buy on Protagonist Therapeutics, Raises Price Target to $28

HC Wainwright & Co. reiterates Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and raises the price target from $23 to $28.

Benzinga · 05/18/2020 11:08

HC Wainwright & Co. reiterates Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and raises the price target from $23 to $28.